Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00059631
Status:
COMPLETED
Last Update Posted:
2018-11-15
First Post:
2003-04-29
Brief Title:
Phase I Study of Weekly Intravenous PS-341 Bortezomib Plus Mitoxantrone
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |